Pharmacogenetics of antidepressant response

Area of Science:

• Pharmacogenomics
• Genetics
• Molecular Medicine

Background:

• Personalized medicine tailors therapies to individual genetic profiles.
• Understanding genotype-drug response is crucial for modern medical practice.
• Antidepressant treatment response varies significantly among individuals.

Purpose of the Study:

• To review current knowledge on genes affecting antidepressant treatment response.
• To propose methodological improvements for future genetic studies in this field.
• To identify promising pharmacodynamic and pharmacokinetic genes related to antidepressant efficacy and side effects.

Main Methods:

• Literature review focusing on genes influencing antidepressant pharmacodynamics and pharmacokinetics.
• Synthesis of findings from studies investigating genotype-drug response.
• Analysis of inconsistencies in current research.

Main Results:

• Several pharmacodynamic genes show promise in predicting antidepressant response, though findings are inconsistent.
• Pharmacokinetic genes appear less relevant than pharmacodynamic genes for antidepressant treatment response.
• Inconsistencies across studies highlight the need for refined research methodologies.

Conclusions:

• Pharmacogenomic markers are vital for optimizing antidepressant selection and dosing.
• Further research with improved study designs is necessary to resolve inconsistencies and enhance personalized antidepressant therapy.
• Future studies should focus on robust methodologies to validate gene-drug associations for clinical application.